News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
Market overviews
Direct comparison of products for laboratory and process: Use the comprehensive market overviews to compare products according to your requirements and obtain further information from suppliers.
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
02-Jun-2010 - Evolva Holding SA announced that Dr. Melya Hughes Crameri, CEO of Evolva’s US subsidiary Genetic Chemistry, has resigned from her role effective June 18th, in order to pursue other opportunities. Dr. Panchapagesa Murali, CEO of Evolva’s Indian subsidiary, will serve as acting CEO of Evolva’s US ...
06-May-2010 - Evolva Holding SA announced the nomination of Sir Tom McKillop, Claus Braestrup and Nicole Dubois for election to its Board of Directors. The three candidates will be proposed for election in the Annual General Meeting (AGM), to be held on 10 June 2010. Tom McKillop was Chief Executive Officer ...
12-Mar-2010 - Evolva Holding SA announced that its Danish subsidiary has commenced a research initiative focusing on novel ways to produce vanillin and arabinogalactan proteins. Together with Evolva, the initiative includes four Danish research groups from the University of Copenhagen and the Danish Technical ...
05-Jan-2010 - Evolva Holding SA announced that it has signed an agreement with Roche to create compounds with activity on targets in oncology and anti-infectives using Evolva’s technology platform. Roche will pay Evolva an up-front technology access fee and ongoing research fees. Roche will have ...
16-Dec-2009 - Aravis announced that it has co-led a highly complex transaction involving the second closing of a total Series B financing of CHF 44 M (USD 43 M) in Evolva SA and the reverse merger of Evolva SA with Arpida Ltd. The merged company was listed on the SIX Swiss Exchange as Evolva Holding ...
29-Oct-2009 - Evolva SA has expanded its management team by appointing Jessica Mann as Chief Medical Officer. She has supported Evolva as an advisor over the last year and has been actively involved in the clinical development of Evolva’s compound portfolio in this period. Jessica Mann, MD, PhD has ...
23-Oct-2009 - Evolva SA announced a CHF 28 million first closing of its Series B financing round. The Series B financing is led by current investor Aravis and new investors Auriga Partners, Vinci Capital - Renaissance PME and Wellington Partners. BioMedInvest and an undisclosed private investor participated ...
27-Aug-2009 - Evolva SA, has expanded its Management team by appointing Jutta Heim as Chief Technology Officer. In her new role, Jutta Heim will lead Evolva’s discovery activities and strengthen the development of our technology platform. Since 2004, Prof. Jutta Heim served as Chief Scientific Officer at ...
17-Jul-2009 - Evolva SA announced it has completed a single ascending dose Phase I clinical trial in healthy volunteers with EV-077-3201-2TBS. The study in 56 healthy male volunteers was conducted over 12 weeks in Germany. The single ascending dose study showed that EV-077-3201-2TBS achieved good exposure ...
20-Mar-2009 - Evolva SA announced it has started Phase I Clinical Trials with its drug candidate EV-077-3201-2TBS. The first-in-man study, a single ascending dose study, will enroll 56 healthy male volunteers and will be conducted in Germany over the next 12 weeks. The purpose of the study is to assess the ...
© 1997-2024 LUMITOS AG, All rights reserved